Loading insider details...
Beta
Latest Form 4 (Mar 26, 2026): Exercise/Conversion of 47,333 OVID shares, $66.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 26, 2026 | Ovid Therapeutics Inc. (OVID) | Exercise/Conversion | 47,333 | $66.3K |
| Mar 2, 2026 | Ovid Therapeutics Inc. (OVID) | Grant/Award | 957,000 | n/a |
| Dec 18, 2025 | Ovid Therapeutics Inc. (OVID) | Conversion | 71,000 | n/a |
| Feb 25, 2025 | Ovid Therapeutics Inc. (OVID) | Grant/Award | 1,650,000 | n/a |
| Mar 20, 2024 | Ovid Therapeutics Inc. (OVID) | Purchase | 18,248 | $50.4K |
| Feb 26, 2024 | Ovid Therapeutics Inc. (OVID) | Grant/Award | 700,000 | n/a |
| Dec 6, 2023 | Ovid Therapeutics Inc. (OVID) | Gift | 573,275 | n/a |
| Feb 27, 2023 | Ovid Therapeutics Inc. (OVID) | Grant/Award | 600,000 | n/a |
| Apr 12, 2022 | Ovid Therapeutics Inc. (OVID) | Grant/Award | 423,244 | n/a |
| Feb 4, 2022 | Ovid Therapeutics Inc. (OVID) | Grant/Award | 600,000 | n/a |